Phase 1 Stomach Cancer Trial, Recruiting (NCT05172310)

Phase 1 Stomach Cancer Trial, Recruiting NCT05172310 Sponsor: Karolinska University Hospital Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05172310 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled for surgery to remove a pancreatic, biliary (bile duct), or stomach lesion
People who are scheduled for their first surgery to remove early-stage ovarian cancer, a surgery to remove as much ovarian cancer as possible after initial treatment, or a surgery or tissue biopsy for ovarian cancer that has come back
People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

People who are 18 years old or younger
People who are pregnant or breastfeeding
People who have significantly reduced kidney function
People who have an allergy to iodinated contrast media (a type of dye used in medical imaging)
People who are unable to make their own decisions independently, such as those with cognitive impairment
People with pancreatic, stomach, or bile duct cancer where the cancer is already known to have spread to other parts of the body

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Rimma Axelsson, Professor, Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital

Phone: +46 708 227 622

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05172310

Sponsor: Karolinska University Hospital

Phase: Phase 1

Status: Recruiting

Condition: Stomach Cancer

Trial contact: +46 708 227 622

More information: https://clinicaltrials.gov/study/NCT05172310

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled for surgery to remove a pancreatic, biliary (bile duct), or stomach lesion
People who are scheduled for their first surgery to remove early-stage ovarian cancer, a surgery to remove as much ovarian cancer as possible after initial treatment, or a surgery or tissue biopsy for ovarian cancer that has come back
People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

People who are 18 years old or younger
People who are pregnant or breastfeeding
People who have significantly reduced kidney function
People who have an allergy to iodinated contrast media (a type of dye used in medical imaging)
People who are unable to make their own decisions independently, such as those with cognitive impairment
People with pancreatic, stomach, or bile duct cancer where the cancer is already known to have spread to other parts of the body

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Karolinska University Hospital

Registry

ClinicalTrials.gov

Start date

2 June 2021

Est. completion

30 June 2024

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Diagnostic accuracy of FAPI-PET/CT in primary tumors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov